Source: Annual Congress 2003 - Risk factors for asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Svanes, F. Gomez Real, T. Gislason, C. Jansson, R. Jogi, E. Norrman, E. Juul-Jensen, K. Toren, O. Ernst (Bergen, Norway). Asthma and hayfever is associated with use of oral contraceptives and hormonal replacement therapy. Eur Respir J 2003; 22: Suppl. 45, 247

Member's Comments

No comment yet.

Related content which might interest you: Cessation of combination therapy for asthma during pregnancy Source: Annual Congress 2010 - Combination therapy in asthma and COPD Year: 2010 Is there a problem with oral corticosteroid use in asthma? Source: Virtual Congress 2020 – Airway diseases Year: 2020 How can we minimise the use of regular oral corticosteroids in asthma? Source: Eur Respir Rev, 29 (155) 190085; 10.1183/16000617.0085-2019 Year: 2020 Changes in the use of anti-asthmatic medication in an international cohort Source: Eur Respir J 2005; 26: 1047-1055 Year: 2005 Prevalence of oral corticosteroid use in the German severe asthma population Source: ERJ Open Res, 5 (4) 00092-2019; 10.1183/23120541.00092-2019 Year: 2019 Response of children with bronchial asthma to combined therapy with an oral immunostimulating drug and antileukotrienes Source: Eur Respir J 2005; 26: Suppl. 49, 159s Year: 2005 Rescue/acute and allergy medication use among children on asthma controller therapy Source: Eur Respir J 2004; 24: Suppl. 48, 378s Year: 2004 Oral corticosteroid prescription in asthma: Swiss situation Source: Virtual Congress 2020 – Clinical and laboratory pharmacology in asthma Year: 2020 Estimation of risk of osteoporosis based on inhaled and oral corticosteroids Source: Eur Respir J 2002; 20: Suppl. 38, 409s Year: 2002 Oral corticosteroids for asthma usually prescribed by non-specialists Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights Year: 2020 Late-breaking abstract: Postmenopausal hormone replacement therapy is associated with increased risk of asthma hospitalization Source: Annual Congress 2011 - Respiratory epidemiology: quality of life, therapy and socioeconomics Year: 2011 Regular use of inhaled corticosteroids and the long-term prevention of hospitalisation for asthma Source: Eur Respir J 2002; 20: Suppl. 38, 8s Year: 2002 Women receiving hormone replacement therapy are at high risk of developing asthma Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases Year: 2020 Oral corticosteroid use in Swedish and Finnish severe asthma patients Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies Year: 2019 Combination therapy of inhaled corticosteroids and long-acting beta2-agonists may be associated with risk reduction of lung cancer in COPD patients who quit smoking Source: Eur Respir J 2006; 28: Suppl. 50, 454s Year: 2006 Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids Source: Breathe 2010; 6: 365 Year: 2010 Maternal obesity and inhaled corticosteroid use in childhood Source: Annual Congress 2012 - Asthma: from childhood environment to adult phenotypes Year: 2012 Adherence to steroid treatment in asthma Source: International Congress 2019 – Inhalers: adherence and preference Year: 2019 Omalizumab therapy reduces oral corticosteroid use in patients with severe allergic (IgE-mediated) asthma: European real-life experience Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009 Osteoporosis in patients with long-term inhaled corticosteroids treatment Source: Eur Respir J 2007; 30: Suppl. 51, 613s Year: 2007